tirzepatide for nash Consistent improvements in liver histology across subgroups in a post hoc analysis of the SYNERGY-NASH trial with Tirzepatide Medication Guide - Nervana
Description
Nur zu Forschungszwecken
An important mechanism of neur...
Read our medical weight loss blog for expert guidance on GLP-1 medications, obesity medicine, nutrition, metabolism, and long-term wellness.
Results: The 90% confidence intervals were 93.11%–107.22% for Cmax, 93.76%–112.65% for AUC0–t, and 91.48%–104.47% for AUC0–∞, meeting bioequivalence criteria for all primary parameters
The findings spell an uncertain future for hospitals and clinics that derive a significant portion of their revenues from obesity procedures.
But Im one of many who had the surgery and still use a GLP-1 to manage my weight, and its working for me.
